A detailed history of California State Teachers Retirement System transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 32,136 shares of OLMA stock, worth $203,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,136
Previous 33,293 3.48%
Holding current value
$203,099
Previous $360,000 6.39%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.41 - $16.46 $12,044 - $19,044
-1,157 Reduced 3.48%
32,136 $383,000
Q2 2024

Aug 14, 2024

SELL
$8.73 - $13.99 $12,239 - $19,613
-1,402 Reduced 4.04%
33,293 $360,000
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $12,395 - $18,813
1,132 Added 3.37%
34,695 $392,000
Q4 2023

Feb 13, 2024

BUY
$10.53 - $17.14 $291,038 - $473,732
27,639 Added 466.56%
33,563 $470,000
Q3 2023

Nov 14, 2023

SELL
$8.19 - $12.98 $24,627 - $39,030
-3,007 Reduced 33.67%
5,924 $73,000
Q2 2023

Aug 21, 2023

BUY
$3.22 - $9.65 $28,757 - $86,184
8,931 New
8,931 $80,000
Q2 2022

Aug 15, 2022

SELL
$2.04 - $4.61 $39,924 - $90,222
-19,571 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.89 - $9.43 $9,499 - $23,028
-2,442 Reduced 11.09%
19,571 $83,000
Q4 2021

Feb 15, 2022

BUY
$8.75 - $30.71 $73,500 - $257,964
8,400 Added 61.71%
22,013 $206,000
Q3 2021

Nov 15, 2021

SELL
$22.96 - $30.13 $71,543 - $93,885
-3,116 Reduced 18.63%
13,613 $375,000
Q2 2021

Aug 16, 2021

SELL
$21.15 - $36.14 $33,205 - $56,739
-1,570 Reduced 8.58%
16,729 $468,000
Q1 2021

May 18, 2021

BUY
$27.81 - $53.64 $508,895 - $981,558
18,299 New
18,299 $607,000

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $255M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.